"overall cancer" trang 8 - tải miễn phí từ tailieunhanh
Outcome of inflammatory breast cancer in Moroccan patients: Clinical, molecular and pathological characteristics of 219 cases from the National Oncology Institute (INO)

Outcome of inflammatory breast cancer in Moroccan patients: Clinical, molecular and pathological characteristics of 219 cases from the National Oncology Institute (INO)
9    85    1
Serum albumin level as a potential marker for deciding chemotherapy or best supportive care in elderly, advanced nonsmall cell lung cancer patients with poor performance status

Serum albumin level as a potential marker for deciding chemotherapy or best supportive care in elderly, advanced nonsmall cell lung cancer patients with poor performance status
8    67    1
Positive prognostic value of HER2-HER3 coexpression and p-mTOR in gastric cancer patients

Positive prognostic value of HER2-HER3 coexpression and p-mTOR in gastric cancer patients
16    67    1
Role of adjuvant chemotherapy in locally advanced rectal cancer with ypT0-3N0 after preoperative chemoradiation therapy and surgery

Role of adjuvant chemotherapy in locally advanced rectal cancer with ypT0-3N0 after preoperative chemoradiation therapy and surgery
10    51    1
Prognostic significance of the total number of harvested lymph nodes for lymph node-negative gastric cancer patients

Prognostic significance of the total number of harvested lymph nodes for lymph node-negative gastric cancer patients
9    59    1
Meta-analysis examining overall survival in patients with pancreatic cancer treated with second-line 5-fluorouracil and oxaliplatin-based therapy after failing firstline gemcitabine-containing therapy: Effect of performance status and comparison with other regimens

Meta-analysis examining overall survival in patients with pancreatic cancer treated with second-line 5-fluorouracil and oxaliplatin-based therapy after failing firstline gemcitabine-containing therapy: Effect of performance status and comparison with other regimens
9    70    1
Reducing the socioeconomic gradient in uptake of the NHS bowel cancer screening Programme using a simplified supplementary information leaflet: A cluster-randomised trial

Reducing the socioeconomic gradient in uptake of the NHS bowel cancer screening Programme using a simplified supplementary information leaflet: A cluster-randomised trial
9    63    1
The optimal extent of gastrectomy for middle third gastric cancer: Distal subtotal gastrectomy is superior to total gastrectomy in short term effect without sacrificing long term survival

The optimal extent of gastrectomy for middle third gastric cancer: Distal subtotal gastrectomy is superior to total gastrectomy in short term effect without sacrificing long term survival
9    96    1
Potential of extravasated platelet aggregation as a surrogate marker for overall survival in patients with advanced gastric cancer treated with preoperative docetaxel, cisplatin and S-1: A retrospective observational study

Potential of extravasated platelet aggregation as a surrogate marker for overall survival in patients with advanced gastric cancer treated with preoperative docetaxel, cisplatin and S-1: A retrospective observational study
11    50    1
Tumor-infiltrating mast cells predict prognosis and gemcitabine-based adjuvant chemotherapeutic benefit in biliary tract cancer patients

Tumor-infiltrating mast cells predict prognosis and gemcitabine-based adjuvant chemotherapeutic benefit in biliary tract cancer patients
9    53    2
The effect of surgery on the survival status of patients with locally advanced cervical cancer after radiotherapy/ chemoradiotherapy: A meta-analysis

The effect of surgery on the survival status of patients with locally advanced cervical cancer after radiotherapy/ chemoradiotherapy: A meta-analysis
10    80    1
EP3 (prostaglandin E2 receptor 3) expression is a prognostic factor for progression-free and overall survival in sporadic breast cancer

EP3 (prostaglandin E2 receptor 3) expression is a prognostic factor for progression-free and overall survival in sporadic breast cancer
9    44    1
Retrospective analysis of the impact of anthracycline dose reduction and chemotherapy delays on the outcomes of early breast cancer molecular subtypes

Retrospective analysis of the impact of anthracycline dose reduction and chemotherapy delays on the outcomes of early breast cancer molecular subtypes
9    33    1
A Phase I clinical trial of EUS-guided intratumoral injection of the oncolytic virus, HF10 for unresectable locally advanced pancreatic cancer

A Phase I clinical trial of EUS-guided intratumoral injection of the oncolytic virus, HF10 for unresectable locally advanced pancreatic cancer
9    27    1
Early prostate-specific antigen response post-abiraterone as predictor of overall survival in metastatic castrate-resistant prostate cancer

Early prostate-specific antigen response post-abiraterone as predictor of overall survival in metastatic castrate-resistant prostate cancer
6    66    1
New pre-treatment eosinophil-related ratios as prognostic biomarkers for survival outcomes in endometrial cancer

New pre-treatment eosinophil-related ratios as prognostic biomarkers for survival outcomes in endometrial cancer
9    60    1
The prognostic impact of decreased pretreatment haemoglobin level on the survival of patients with lung cancer: A systematic review and meta-analysis

The prognostic impact of decreased pretreatment haemoglobin level on the survival of patients with lung cancer: A systematic review and meta-analysis
15    35    1
MiR-20a, a novel promising biomarker to predict prognosis in human cancer: A metaanalysis

MiR-20a, a novel promising biomarker to predict prognosis in human cancer: A metaanalysis
14    48    1
Crizotinib in advanced non-small-cell lung cancer with concomitant ALK rearrangement and c-Met overexpression

Crizotinib in advanced non-small-cell lung cancer with concomitant ALK rearrangement and c-Met overexpression
9    54    1
Down-regulation of A-FABP predicts nonmuscle invasive bladder cancer progression: Investigation with a long term clinical follow-up

Down-regulation of A-FABP predicts nonmuscle invasive bladder cancer progression: Investigation with a long term clinical follow-up
13    55    1